title: Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease.
abstract: Environmental stressor exposure is associated with a variety of age-related diseases including neurodegeneration. Although the initial events of sporadic Parkinson's disease (PD) are not known, consistent evidence supports the hypothesis that the disease results from the combined effect of genetic and environmental risk factors. Among them, behavioral stress has been shown to cause damage and neuronal loss in different areas of the brain, however, its effect on the dopaminergic system and PD pathogenesis remains to be characterized. The C57BL/6 mice underwent chronic restraint/isolation (RI) stress and were then treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), whereas the control mice were treated only with MPTP and the effect on the PD-like phenotype was evaluated. The mice that underwent RI before the administration of MPTP manifested an exaggerated motor deficit and impairment in the acquisition of motor skills, which were associated with a greater loss of neuronal tyrosine hydroxylase and astrocytes activation. By showing that RI influences the onset and progression of the PD-like phenotype, our study underlines the novel pathogenetic role that chronic behavioral stressor has in the disease process by triggering neuroinflammation and degeneration of the nigral dopaminergic system.
authors: Department of Pharmacology and Center for Translational Medicine, School of Medicine, Temple University, Philadelphia, PA, USA.
authors: E
authors: E
authors: Lauretti
authors: Department of Pharmacology and Center for Translational Medicine, School of Medicine, Temple University, Philadelphia, PA, USA.
authors: A
authors: A
authors: Di Meco
authors: Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA, USA.
authors: S
authors: S
authors: Merali
authors: Department of Pharmacology and Center for Translational Medicine, School of Medicine, Temple University, Philadelphia, PA, USA.
authors: D
authors: D
authors: Praticò
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000503:physiopathology*; D002908:Chronic Disease; D004195:Disease Models, Animal; D005260:Female; D007249:Inflammation / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D000068079:Motor Disorders / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D010300:Parkinson Disease / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D013315:Stress, Psychological / Q000150:complications / Q000503:physiopathology* / Q000523:psychology
chemical_list: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine